Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01227343 · ClinicalTrials.gov registry record
Nicotine and Brain Imaging Research Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 54
- Enrollment target
NCT01227343: Completed study, sponsored by University of Pennsylvania.
NCT01227343 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01227343 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The aim of this study is to assess the impact of smoking on cortical GABA levels in males and females. Using magnetic resonance spectroscopy (MRS), we will examine the impact of sex and menstrual cycle phase on brain neurochemistry in healthy smokers and non-smokers. We hypothesize that female, but not male, smokers will have reduced cortical GABA levels compared to their non-smoking, sex-matched counterparts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-03 |
| Est. Completion | 2017-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01227343
The ClinicalTrials.gov registry entry for NCT01227343 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01227343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01227343 about?
NCT01227343 is a clinical study titled "Nicotine and Brain Imaging Research Study". The aim of this study is to assess the impact of smoking on cortical GABA levels in males and females. Using magnetic resonance spectroscopy (MRS), we will examine the impact of sex and menstrual cycle phase on brain neurochemistry in healthy smokers and non-smokers. We hypothesize that female, but ...
What is the current status of trial NCT01227343?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2010-03. Estimated completion is 2017-11.
Who is sponsoring clinical trial NCT01227343?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.